NIH Awards $36.3 Million for Pan-Coronavirus Vaccine Research
- October 01, 2021
The National Institutes of Health (NIH), through the National Institute of Allergy and Infectious Diseases (NIAID), has awarded $36.3 million for research to develop vaccines for potential pandemic-causing coronaviruses in the future, the agency announced September 28.
NIAID awarded the funding to three academic institutions—the University of Wisconsin, Madison; Brigham and Women’s Hospital, Boston; and Duke University, Durham, NC—to conduct research on pan-coronavirus vaccine candidates that provide broad protection from multiple coronavirus strains.
“The available COVID-19 vaccines have proven to be remarkably effective at protecting against severe disease and death,” said NIAID Director Anthony S. Fauci, MD. “These new awards are designed to look ahead and prepare for the next generation of coronaviruses with pandemic potential.”
The new awards build on the $1.2 billion NIAID has invested in coronavirus vaccine research since the start of the COVID-19 pandemic, the agency said.